Aprotinin associated with increased risk of death
Wednesday, May 14, 2008 - 19:07
in Health & Medicine
Aprotinin is associated with a 50 per cent increase in the relative risk of death, according to a major Canadian clinical trial comparing three drugs routinely used to prevent blood loss during heart surgery. The trial, published in the New England Journal of Medicine, shows that approximately six per cent of patients who received aprotinin died within 30 days of surgery compared to four per cent of patients who received tranexamic acid or aminocaproic acid.
Read the whole article on Biology News Net
More from Biology News Net
Related
- Aprotinin associated with increased risk of deathWed, 14 May 2008, 13:35:51 EDT
- Risk of death may be higher with drug commonly used during cardiac surgeryTue, 2 Dec 2008, 13:15:55 EST
- Treatment with folic acid, vitamin B12 associated with increased risk of cancer, deathTue, 17 Nov 2009, 19:00:58 EST
- Study finds link between atrial fibrillation and an increased risk of death in diabetic patientsWed, 11 Mar 2009, 20:37:45 EDT
- Death rates same for diabetes and heart disease patients receiving drug therapy or surgerySun, 7 Jun 2009, 17:49:18 EDT